Post by Novotech
135,122 followers
Strong partnerships are critical to advancing oncology research. That’s why Novotech partnered with The START Center for Cancer Research, one of the world’s largest early-phase, community-based oncology site networks across the US and Europe. Together, we’re focused on helping sponsors navigate the growing complexity of oncology trials. Sarah Rose Anderson, Director of Therapeutic Strategy at Novotech sat down with START in a 3-part series to discuss their expertise, extensive PI network, and advanced PK capabilities and why these strengths matter in early-phase oncology development. Also available as a podcast on Spotify https://lnkd.in/grvVCS4d #Oncology #ClinicalTrials #Biotech #START
Video Content